Good news in the first months of the RSV vaccine rollout

Since the start of February, pregnant women have been eligible to get vaccinated against respiratory syncytial virus (RSV). 

The vaccine is administered during the 28 to 36 week mark of pregnancy to protect newborns from RSV. 

As of June, more than 60,000 women had received the vaccine. 

Guest/s

• Professor Jim Buttery, Murdoch Children's Research Institute and infectious diseases physician at the Royal Children's Hospital in Melbourne

References

• Respiratory syncytial virus preventives for children in Australia: current landscape and future directions